These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23313081)

  • 1. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.
    Krastins B; Prakash A; Sarracino DA; Nedelkov D; Niederkofler EE; Kiernan UA; Nelson R; Vogelsang MS; Vadali G; Garces A; Sutton JN; Peterman S; Byram G; Darbouret B; Pérusse JR; Seidah NG; Coulombe B; Gobom J; Portelius E; Pannee J; Blennow K; Kulasingam V; Couchman L; Moniz C; Lopez MF
    Clin Biochem; 2013 Apr; 46(6):399-410. PubMed ID: 23313081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts.
    Gauthier MS; Pérusse JR; Awan Z; Bouchard A; Tessier S; Champagne J; Krastins B; Byram G; Chabot K; Garneau P; Rabasa-Lhoret R; Faubert D; Lopez MF; Seidah NG; Coulombe B
    Methods; 2015 Jun; 81():66-73. PubMed ID: 25770357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM).
    Peterman S; Niederkofler EE; Phillips DA; Krastins B; Kiernan UA; Tubbs KA; Nedelkov D; Prakash A; Vogelsang MS; Schoeder T; Couchman L; Taylor DR; Moniz CF; Vadali G; Byram G; Lopez MF
    Proteomics; 2014 Jun; 14(12):1445-56. PubMed ID: 24668948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.
    Niederkofler EE; Phillips DA; Krastins B; Kulasingam V; Kiernan UA; Tubbs KA; Peterman SM; Prakash A; Diamandis EP; Lopez MF; Nedelkov D
    PLoS One; 2013; 8(11):e81125. PubMed ID: 24278387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.
    Oran PE; Trenchevska O; Nedelkov D; Borges CR; Schaab MR; Rehder DS; Jarvis JW; Sherma ND; Shen L; Krastins B; Schwenke DC; Reaven PD; Nelson RW
    PLoS One; 2014; 9(3):e92801. PubMed ID: 24664114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.
    Lopez MF; Rezai T; Sarracino DA; Prakash A; Krastins B; Athanas M; Singh RJ; Barnidge DR; Oran P; Borges C; Nelson RW
    Clin Chem; 2010 Feb; 56(2):281-90. PubMed ID: 20022981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies.
    Oran PE; Jarvis JW; Borges CR; Sherma ND; Nelson RW
    Proteomics Clin Appl; 2011 Aug; 5(7-8):454-9. PubMed ID: 21656909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep-Dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues.
    Nie S; Shi T; Fillmore TL; Schepmoes AA; Brewer H; Gao Y; Song E; Wang H; Rodland KD; Qian WJ; Smith RD; Liu T
    Anal Chem; 2017 Sep; 89(17):9139-9146. PubMed ID: 28724286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes.
    Yassine H; Borges CR; Schaab MR; Billheimer D; Stump C; Reaven P; Lau SS; Nelson R
    Proteomics Clin Appl; 2013 Aug; 7(7-8):528-40. PubMed ID: 23696124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative mass spectrometric immunoassay of insulin like growth factor 1.
    Nelson RW; Nedelkov D; Tubbs KA; Kiernan UA
    J Proteome Res; 2004; 3(4):851-5. PubMed ID: 15359740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum.
    Shi T; Fillmore TL; Sun X; Zhao R; Schepmoes AA; Hossain M; Xie F; Wu S; Kim JS; Jones N; Moore RJ; Pasa-Tolić L; Kagan J; Rodland KD; Liu T; Tang K; Camp DG; Smith RD; Qian WJ
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15395-400. PubMed ID: 22949669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion.
    Shi T; Sun X; Gao Y; Fillmore TL; Schepmoes AA; Zhao R; He J; Moore RJ; Kagan J; Rodland KD; Liu T; Liu AY; Smith RD; Tang K; Camp DG; Qian WJ
    J Proteome Res; 2013 Jul; 12(7):3353-61. PubMed ID: 23763644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.
    Shi T; Su D; Liu T; Tang K; Camp DG; Qian WJ; Smith RD
    Proteomics; 2012 Apr; 12(8):1074-92. PubMed ID: 22577010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of proteins using peptide immunoaffinity enrichment coupled with mass spectrometry.
    Zhao L; Whiteaker JR; Pope ME; Kuhn E; Jackson A; Anderson NL; Pearson TW; Carr SA; Paulovich AG
    J Vis Exp; 2011 Jul; (53):. PubMed ID: 21841765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.
    Trenchevska O; Schaab MR; Nelson RW; Nedelkov D
    Methods; 2015 Jun; 81():86-92. PubMed ID: 25752847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and isoform-specific quantitative assessment of circulating fibulin-1 using selected reaction monitoring MS and time-resolved immunofluorometry.
    Overgaard M; Cangemi C; Jensen ML; Argraves WS; Rasmussen LM
    Proteomics Clin Appl; 2015 Aug; 9(7-8):767-75. PubMed ID: 25331251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.
    Trenchevska O; Sherma ND; Oran PE; Reaven PD; Nelson RW; Nedelkov D
    J Proteomics; 2015 Feb; 116():15-23. PubMed ID: 25549571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robotic protocol for high-throughput processing of samples for selected reaction monitoring assays.
    Zhu M; Zhang P; Geng-Spyropoulos M; Moaddel R; Semba RD; Ferrucci L
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 27862927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.